Rights and permissions
About this article
Cite this article
ECP cost effective vs new agents in chronic GVHD. Pharmacoecon. Outcomes News 661, 8 (2012). https://doi.org/10.2165/00151234-201206610-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206610-00020